SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 79.78 |
| Enterprise Value ($M) | 45.95 |
| Book Value ($M) | 30.04 |
| Book Value / Share | 0.62 |
| Price / Book | 2.66 |
| NCAV ($M) | 20.76 |
| NCAV / Share | 0.43 |
| Price / NCAV | 3.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.16 |
| Return on Assets (ROA) | -0.61 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.47 |
| Current Ratio | 2.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 44.67 |
| Assets | 53.95 |
| Liabilities | 23.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.49 |
| Operating Income | -51.99 |
| Net Income | -50.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -39.96 |
| Cash from Investing | 25.00 |
| Cash from Financing | 11.86 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bleichroeder LP | 6.11 | ||
| 13G | BlackRock Inc. | 4.98 | -3.88 | |
| 13D | Marlett Christopher A | 68.20 | 1,288.62 | |
| 13D | Digiandomenico Anthony | 22.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 71,811 | 246,674 | 29.11 | |
| 52,609 | 263,507 | 19.96 | |
| 104,964 | 187,178 | 56.08 | |
| 22,602 | 98,120 | 23.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRVO – CervoMed Inc. | CSBR – Champions Oncology, Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io